THIRD RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 19th, 2009 • Talecris Biotherapeutics Holdings Corp. • Pharmaceutical preparations • North Carolina
Contract Type FiledAugust 19th, 2009 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT between Talecris Biotherapeutics Holdings Corporation (the “Company”) and Lawrence D. Stern (the “Executive”) (together, the “Parties”) was effective as of April 1, 2005 (the “Effective Date”) and was amended and restated as of April 1, 2007 (the “Original Restatement Date”), with all terms retroactive to such date, was hereby amended and restated as of January 1, 2009, and is hereby further amended and restated as of April 1, 2009 (the “Third Restatement Date”).
September 15, 2006Stock Purchase Agreement • August 19th, 2009 • Talecris Biotherapeutics Holdings Corp. • Pharmaceutical preparations
Contract Type FiledAugust 19th, 2009 Company Industry
STOCKHOLDERS AGREEMENT among TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. TALECRIS HOLDINGS, LLC and BAYER HEALTHCARE LLC AND ITS AFFILIATES PARTY HERETO Dated as of March 31, 2005Shareholder Agreements • August 19th, 2009 • Talecris Biotherapeutics Holdings Corp. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 19th, 2009 Company Industry JurisdictionSTOCKHOLDERS AGREEMENT (this “Agreement”), dated as of March 31, 2005 (the “Effective Date”), among TALECRIS BIOTHERAPEUTICS HOLDINGS CORP., a Delaware corporation (the “Company”), TALECRIS HOLDINGS, LLC, a Delaware limited liability company (“Talecris LLC”), BAYER HEALTHCARE LLC, a Delaware limited liability company (“Bayer”), and the Affiliates of Bayer listed on Schedule I hereto (together with Bayer, the “Bayer Parties”). Talecris LLC and the Bayer Parties are collectively referred to as the “Stockholders”. Capitalized terms not defined herein have the meanings assigned to them in the Joint Contribution Agreement (as defined below).
AGREEMENT FOR DOMESTIC AND GLOBAL RELOCATION SERVICESAgreement for Domestic and Global Relocation Services • August 19th, 2009 • Talecris Biotherapeutics Holdings Corp. • Pharmaceutical preparations • North Carolina
Contract Type FiledAugust 19th, 2009 Company Industry JurisdictionThis agreement (this “Agreement”) is made as of the 14th day of July, 2008 (the “Effective Date”), between GMAC Global Relocation Services, LLC (“GMAC GRS”), a Delaware limited liability company, having its principal place of business at 2021 Spring Road, Suite 300, Oak Brook, IL 60523 and Talecris Biotherapeutics, Inc. (“Talecris”), having its principal place of business at 79 T.W. Alexander Drive, Research Triangle Park, NC 27513.
AMENDED AND RESTATED PLASMA SALE/PURCHASE AGREEMENTPlasma Sale/Purchase Agreement • August 19th, 2009 • Talecris Biotherapeutics Holdings Corp. • Pharmaceutical preparations • North Carolina
Contract Type FiledAugust 19th, 2009 Company Industry JurisdictionThis Amended and Restated Plasma Sale/Purchase Agreement (the “Agreement”) is made, entered into and effective as of the 13th day of October, 2006 (the “Effective Date”) by and between Interstate Blood Bank, Inc. doing business as IBBI having an address at 5700 Pleasant View Road, Memphis, TN 38134 (“Supplier”) and Talecris Biotherapeutics, Inc., having an address at 79 T.W. Alexander Drive, 4101 Research Commons, Research Triangle Park, North Carolina 27709 (“Talecris”). Supplier and Talecris are at times referred to in this Agreement individually as a “Party” and collectively as the “Parties”.
AMENDMENT TO AGREEMENT FOR DOMESTIC AND GLOBAL RELOCATION SERVICESAgreement for Domestic and Global Relocation Services • August 19th, 2009 • Talecris Biotherapeutics Holdings Corp. • Pharmaceutical preparations
Contract Type FiledAugust 19th, 2009 Company IndustryThis Amendment is entered into this 15th day of August, 2006 (the “Effective Date”) and modifies a certain Agreement for Domestic and Global Relocation Services made as of the 14th day of July, 2008 (the “Agreement”), by and between GMAC Global Relocation Services, LLC a Delaware limited liability company, having an address at 2021 Spring Road, Suite 300, Oak Brook, IL 60523 (“GMAC GRS”). and Talecris Biotherapeutics, Inc. (“the Company”), with an office at 79 T.W. Alexander Drive, 4101 research Commons, Research Triangle Park, NC 27709.